vs
Side-by-side financial comparison of CHIMERA INVESTMENT CORP (CIM) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
CHIMERA INVESTMENT CORP is the larger business by last-quarter revenue ($66.2M vs $61.6M, roughly 1.1× ORTHOPEDIATRICS CORP). CHIMERA INVESTMENT CORP runs the higher net margin — 42.8% vs -16.4%, a 59.2% gap on every dollar of revenue. On growth, ORTHOPEDIATRICS CORP posted the faster year-over-year revenue change (17.0% vs 0.5%). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs 0.8%).
Chimera Investment Corp is a US-based real estate investment trust (REIT) primarily investing in residential mortgage-backed securities, residential and commercial mortgage loans, and other real estate-related financial assets. It delivers sustainable risk-adjusted returns for shareholders via regular dividend distributions from its investment portfolio.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
CIM vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.2M | $61.6M |
| Net Profit | $28.3M | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | 42.6% | -13.3% |
| Net Margin | 42.8% | -16.4% |
| Revenue YoY | 0.5% | 17.0% |
| Net Profit YoY | 119.3% | 37.1% |
| EPS (diluted) | $0.05 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $66.2M | $61.6M | ||
| Q3 25 | $65.0M | $61.3M | ||
| Q2 25 | $66.0M | $61.1M | ||
| Q1 25 | $69.2M | $52.4M | ||
| Q4 24 | $65.8M | $52.7M | ||
| Q3 24 | $66.5M | $54.6M | ||
| Q2 24 | $67.3M | $52.8M | ||
| Q1 24 | $65.1M | $44.7M |
| Q4 25 | $28.3M | $-10.1M | ||
| Q3 25 | $-580.0K | $-11.8M | ||
| Q2 25 | $35.5M | $-7.1M | ||
| Q1 25 | $167.3M | $-10.7M | ||
| Q4 24 | $-146.5M | $-16.1M | ||
| Q3 24 | $136.5M | $-7.9M | ||
| Q2 24 | $56.7M | $-6.0M | ||
| Q1 24 | $129.5M | $-7.8M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% | ||
| Q1 24 | — | 72.0% |
| Q4 25 | 42.6% | -13.3% | ||
| Q3 25 | -0.5% | -15.4% | ||
| Q2 25 | 54.3% | -17.4% | ||
| Q1 25 | — | -21.0% | ||
| Q4 24 | -222.6% | -26.7% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | 84.2% | -10.7% | ||
| Q1 24 | — | -21.8% |
| Q4 25 | 42.8% | -16.4% | ||
| Q3 25 | -0.9% | -19.2% | ||
| Q2 25 | 53.7% | -11.6% | ||
| Q1 25 | 241.7% | -20.3% | ||
| Q4 24 | -222.6% | -30.5% | ||
| Q3 24 | 205.4% | -14.5% | ||
| Q2 24 | 84.2% | -11.4% | ||
| Q1 24 | 198.8% | -17.5% |
| Q4 25 | $0.05 | $-0.43 | ||
| Q3 25 | $-0.27 | $-0.50 | ||
| Q2 25 | $0.17 | $-0.30 | ||
| Q1 25 | $1.77 | $-0.46 | ||
| Q4 24 | $-2.06 | $-0.70 | ||
| Q3 24 | $1.39 | $-0.34 | ||
| Q2 24 | $0.41 | $-0.26 | ||
| Q1 24 | $1.36 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $278.6M | $60.9M |
| Total DebtLower is stronger | $251.5M | $106.0M |
| Stockholders' EquityBook value | $2.6B | $346.6M |
| Total Assets | $15.8B | $508.6M |
| Debt / EquityLower = less leverage | 0.10× | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.6M | $60.9M | ||
| Q3 25 | $491.5M | $57.7M | ||
| Q2 25 | $250.2M | $70.1M | ||
| Q1 25 | $253.3M | $58.8M | ||
| Q4 24 | $84.0M | $68.8M | ||
| Q3 24 | $97.3M | $76.1M | ||
| Q2 24 | $162.3M | $28.9M | ||
| Q1 24 | $169.0M | $47.7M |
| Q4 25 | $251.5M | $106.0M | ||
| Q3 25 | $251.0M | $105.3M | ||
| Q2 25 | $135.2M | $102.7M | ||
| Q1 25 | $134.9M | $77.4M | ||
| Q4 24 | $134.6M | $77.5M | ||
| Q3 24 | $134.4M | $76.9M | ||
| Q2 24 | $62.4M | $11.2M | ||
| Q1 24 | — | $11.3M |
| Q4 25 | $2.6B | $346.6M | ||
| Q3 25 | $2.6B | $349.3M | ||
| Q2 25 | $2.6B | $355.5M | ||
| Q1 25 | $2.6B | $347.1M | ||
| Q4 24 | $2.5B | $354.6M | ||
| Q3 24 | $2.7B | $370.9M | ||
| Q2 24 | $2.6B | $371.3M | ||
| Q1 24 | $2.6B | $370.6M |
| Q4 25 | $15.8B | $508.6M | ||
| Q3 25 | $15.1B | $493.5M | ||
| Q2 25 | $14.9B | $503.6M | ||
| Q1 25 | $13.2B | $470.3M | ||
| Q4 24 | $13.1B | $473.2M | ||
| Q3 24 | $13.7B | $489.3M | ||
| Q2 24 | $13.1B | $430.8M | ||
| Q1 24 | $12.5B | $437.2M |
| Q4 25 | 0.10× | 0.31× | ||
| Q3 25 | 0.10× | 0.30× | ||
| Q2 25 | 0.05× | 0.29× | ||
| Q1 25 | 0.05× | 0.22× | ||
| Q4 24 | 0.05× | 0.22× | ||
| Q3 24 | 0.05× | 0.21× | ||
| Q2 24 | 0.02× | 0.03× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-248.9M | $10.3M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 15.8% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | -8.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-248.9M | $10.3M | ||
| Q3 25 | $-137.5M | $-581.0K | ||
| Q2 25 | $-7.4M | $-10.5M | ||
| Q1 25 | $48.8M | $-4.2M | ||
| Q4 24 | $205.7M | $-4.0M | ||
| Q3 24 | $41.4M | $-10.3M | ||
| Q2 24 | $69.0M | $-6.1M | ||
| Q1 24 | $57.3M | $-6.7M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | — | $-8.4M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | — | $-13.2M |
| Q4 25 | — | 15.8% | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | — | -22.8% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | -21.4% | ||
| Q2 24 | — | -24.2% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 12.7% | ||
| Q1 24 | — | 14.5% |
| Q4 25 | -8.78× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.21× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.30× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 0.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
